Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients

BACKGROUND: Healthcare delivery was disrupted during the COVID-19 pandemic, requiring minimized in-person contact between patients and clinicians. During the pandemic, people with opioid use disorder (OUD) were not only at elevated risk for COVID-19, but had markedly reduced access to treatment for...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivakumar, Anishaa, Madden, Lynn, DiDomizio, Elizabeth, Eller, Anthony, Villanueva, Merceditas, Altice, Frederick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685180/
https://www.ncbi.nlm.nih.gov/pubmed/34954493
http://dx.doi.org/10.1016/j.drugpo.2021.103570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685180/
https://www.ncbi.nlm.nih.gov/pubmed/34954493
http://dx.doi.org/10.1016/j.drugpo.2021.103570

Ejemplares similares